The state-run website—HealthCost—reduced medical imaging costs by five percent for patients and four percent for insurers, according to Zach Brown, PhD, an assistant professor of economics at the University of Michigan in Ann Arbor.

In 2018, the FDA approved a total of 106 new medical devices including medical imaging technologies—surpassing their record in 2017 of 99 novel device approvals, according to a recent statement from FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director of the Center for Devices and Radiological Health.

A free lung cancer screening program using National Comprehensive Cancer Network (NCCN) guidelines detected more cancers and ultimately generated profit for the institution conducting the screenings, according to a single-center study published in The Annals of Thoracic Surgery.

"In taking these new steps today, we’re reaffirming our commitment to continually strengthening our review process, so that it can continue to serve and protect American patients well for years to come,” wrote FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health (CDRH), in a recent statement.

The Medical Imaging & Technology Alliance (MITA) announced that Dennis Durmis, senior vice president of Bayer Radiology, Americas region, will be the next chair of its Board of Directors.

On Thursday, Jan. 17, the Virginia's State Senate’s Education and Health Committee voted not to send the bill to the full state Senate for a vote, according to a recent report by the Daily Press in Newport News, Virginia.

The FDA recently gave 501(k) clearance to medical imaging device iCertainty which noninvasively shows blood flow without the need of injection, dyes or radiation.

A coordinated program to reduce fluoroscopy radiation resulted in a three- to eight-fold reduction in high-dose procedures performed over an eight-year period, according to a single-center study published Jan. 15 in Radiology.